{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T03:08:51Z","timestamp":1696302531132},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/ico.0b013e318245c044","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T22:32:29Z","timestamp":1335306749000},"page":"1342-1343","source":"Crossref","is-referenced-by-count":9,"title":["A Case of Recipient Bed Melt and Wound Dehiscence After Penetrating Keratoplasty and Subconjunctival Injection of Bevacizumab"],"prefix":"10.1097","volume":"31","author":[{"given":"Purendra","family":"Bhasin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prateek","family":"Gujar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyamvada","family":"Bhasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-23-20210204","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":". Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"R2-23-20210204","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","article-title":"Anti-vascular endothelial growth factor therapy for ocular neovascular disease.","volume":"18","author":"Andreoli","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"R3-23-20210204","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00007890-198807000-00003","article-title":"An animal model for corneal graft rejection in high-risk keratoplasty.","volume":"46","author":"Hill","year":"1988","journal-title":"Transplantation"},{"key":"R4-23-20210204","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/ICO.0b013e3180de1d0a","article-title":". Safety profile of bevacizumab on cultured human corneal cells.","volume":"26","author":"Yoeruek","year":"2007","journal-title":"Cornea"},{"key":"R5-23-20210204","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1167\/iovs.10-5669","article-title":". Antifibrotic activity of bevacizumab on human Tenons fibroblasts in vitro.","volume":"51","author":"ONeill","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-23-20210204","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-23-20210204","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":". The effect of topical bevacizumab on corneal neovascularization.","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"key":"R8-23-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3928\/15428877-20100215-07","article-title":"Corneal melt while using topical bevacizumab eye drops.","volume":"41","author":"Galor","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R10-23-20210204","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":". Vascular endothelial growth factor and angiogenesis.","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol Rev"},{"key":"R11-23-20210204","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.4161\/cc.7.13.6240","article-title":". Regulating the angiogenic balance in tissues.","volume":"7","author":"Polling","year":"2008","journal-title":"Cell Cycle"},{"key":"R12-23-20210204","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/labinvest.2008.36","article-title":". Regulation of scar formation by vascular endothelial growth factor.","volume":"88","author":"Wilgus","year":"2008","journal-title":"Lab Invest"},{"key":"R13-23-20210204","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1167\/iovs.07-1418","article-title":". Vascular endothelial growth factor mediates corneal nerve repair.","volume":"49","author":"Yu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-23-20210204","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":". Topical Bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R15-23-20210204","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer.","volume":"96","author":"Kamba","year":"2007","journal-title":"Br J Cancer"},{"key":"R16-23-20210204","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2146\/ajhp080455","article-title":". Understanding and managing the possible adverse effects associated with bevacizumab.","volume":"66","author":"Shord","year":"2009","journal-title":"Am J Health Syst Pharm"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e318245c044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T07:50:28Z","timestamp":1687420228000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201211000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318245c044","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}